Latest market price
10.72
-0.26-2.37%
TA
Loading chart...
Snapshot
| Index | — | P/E | 21.53 | EPS (ttm) | 0.51 | Insider Own | 2.59% | Shs Outstand | 68.80M | Perf Week | 7.02% |
| Market Cap | 755.47M | Forward P/E | 7.55 | EPS next Y | 1.46 | Insider Trans | -1.37% | Shs Float | 68.28M | Perf Month | 3.10% |
| Enterprise Value | 2.03B | PEG | — | EPS next Q | 0.37 | Short Float | 4.41% | Perf Quarter | 4.67% | ||
| Income | 37.00M | P/S | 3.16 | EPS this Y | -6.41% | Short Ratio | 5.85 | Perf Half Y | -8.80% | ||
| Sales | 239.00M | P/B | 0.70 | EPS next Y | 1.75% | ROA | 1.51% | Short Interest | 3.01M | Perf YTD | -12.09% |
| Book/sh | 15.70 | P/C | 29.06 | EPS next 5Y | -2.02% | ROE | 3.25% | 52W High | 13.28 -19.28% | Perf Year | -12.58% |
| Cash/sh | 0.38 | P/FCF | 2.53 | EPS past 3/5Y | -12.16% 65.76% | ROIC | 4.08% | 52W Low | 9.95 7.74% | Perf 3Y | -18.67% |
| Dividend Est. | 1.40 (13.06%) | EV/EBITDA | 18.47 | Sales past 3/5Y | 12.52% 30.16% | Gross Margin | 80.59% | Volatility | 1.83% 2.30% | Perf 5Y | -22.57% |
| Dividend TTM | 1.50 (13.99%) | EV/Sales | 8.50 | EPS Y/Y TTM | -56.81% | Oper. Margin | 43.03% | ATR (14) | 0.25 | Perf 10Y | — |
| Dividend Ex-Date | Sep 30, 2026 | Quick Ratio | 0.45 | Sales Y/Y TTM | 55.19% | Profit Margin | 15.53% | RSI (14) | 59.69 | Recom | 2.86 |
| Dividend Gr. 3/5Y | 1.20% 2.95% | Current Ratio | 0.45 | EPS Q/Q | -10.26% | SMA20 | 5.00% | Beta | 0.72 | Target Price | 11.00 |
| Payout | 311.18% | Debt/Eq | 1.21 | Sales Q/Q | 53.85% | SMA50 | -0.12% | Rel Volume | 1.02 | Prev Close | 10.98 |
| Employees | 2,500 | LT Debt/Eq | 1.21 | Earnings | Nov 05 | SMA200 | -1.43% | Avg Volume | 491.00K | Price | 10.72 |
| IPO Date | Jun 14, 2017 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 10.90% 4.47% | Net Debt/EBITDA | 11.60 | Volume | 501,587 | Change | -2.37% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Oct-22-26 | Reiterated | Raymond James | $12 → $11 | |
| Sep-29-26 | Downgrade | Wells Fargo | Overweight → Equal Weight | $12 → $11 |
| May-13-26 | Reiterated | Wells Fargo | Overweight | $15 → $12 |
| Oct-07-25 | Reiterated | Raymond James | $15 | |
| Oct-01-25 | Upgrade | JP Morgan | Underweight → Neutral | |
| Jul-25-25 | Upgrade | Wells Fargo | Equal Weight → Overweight | $16 → $15 |
| Aug-06-24 | Reiterated | Wells Fargo | Equal Weight | $16 |
| Jul-29-24 | Downgrade | JP Morgan | Neutral → Underweight | |
| Sep-06-22 | Downgrade | JP Morgan | Overweight → Neutral | |
| Aug-06-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
Latest News· Times ET
Oct-29-26
Oct-18-26
Oct-18-2601:58AM
Oct-16-26
Oct-16-2604:25PM
Oct-09-26
Oct-09-2606:22PM
Oct-06-26
Oct-06-2603:17AM
Sep-29-26
Sep-29-2604:42AM
Sep-28-26
Sep-28-2608:11AM
Sep-18-26
Sep-16-26
Aug-26-26
Aug-26-2610:30AM
Aug-12-26
Aug-12-2609:08AM
Aug-07-26
Aug-07-2606:54PM
12:06PM
Carlyle Secured Lending Q2 Earnings Call Highlightsmarketbeat.com
Aug-06-26
Aug-06-2611:36PM
Company
Carlyle Secured Lending, Inc. functions as a business development company, primarily making direct investments. The firm provides a diverse array of financing, including first and second lien senior secured loans, unsecured debt, mezzanine debt, and equity stakes. It focuses its investment efforts on the middle market segment. Industries of interest include healthcare and pharmaceuticals, aerospace and defense, high technology, business services, software, the beverage, food, and tobacco sectors, hospitality, gaming, and leisure, banking, finance, and insurance, and real estate. Geographically, Carlyle Secured Lending invests in companies located in the United States, Luxembourg, the Cayman Islands, Cyprus, and the United Kingdom. It typically targets businesses generating an EBITDA between $25 million and $100 million.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 239 | 198 | 168 | 173 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 46 | 58 | 68 | 72 | — | — | — | — | — | |
| Gross Profit | 193 | 140 | 99 | 101 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 8 | 8 | 8 | 6 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 82 | -38 | 0 | 0 | — | — | — | — | — | |
| Operating Income | 102 | 170 | 92 | 95 | — | — | — | — | — | |
| Interest Expense | 90 | 88 | 68 | 72 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 27 | -10 | 68 | 72 | — | — | — | — | — | |
| Net Income Before Taxes | 39 | 72 | 92 | 95 | — | — | — | — | — | |
| Income Taxes | 2 | 2 | 3 | 2 | — | — | — | — | — | |
| Consolidated Net Income | 37 | 70 | 89 | 92 | — | — | — | — | — | |
| Net Income From Continuing Operations | 37 | 70 | 89 | 92 | — | — | — | — | — | |
| Net Income | 37 | 70 | 89 | 92 | — | — | — | — | — | |
| EPS (Recurring) | 0.51 | 1.02 | 1.68 | 1.75 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.51 | 1.02 | 1.68 | 1.75 | — | — | — | — | — | |
| EPS (Diluted) | 0.51 | 1.01 | 1.58 | 1.64 | — | — | — | — | — | |
| EBITDA | 110 | 165 | 95 | 95 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 21.02 | 12.37 | 11.35 | 9.12 | — | — | — | — | — | |
| Price To Sales Ratio | 3.18 | 4.29 | 5.44 | 4.67 | — | — | — | — | — | |
| Gross Margin | 80.75 | 70.71 | 58.93 | 58.38 | — | — | — | — | — | |
| Operating Margin | 42.68 | 85.86 | 54.76 | 54.91 | — | — | — | — | — | |
| Net Margin | 15.48 | 35.35 | 52.98 | 53.18 | — | — | — | — | — | |
| Shares Outstanding | 71 | 68 | 51 | 54 | — | — | — | — | — | |
| Market Capitalization | 761 | 849 | 914 | 808 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Nestor John G. | Director | Aug 12 '26 | Sale | 11.20 | 16,813 | 188,242 | 0 | Aug 17 |
| Nestor John G. | Director | Jun 01 '26 | Sale | 10.97 | 1,617 | 17,741 | 2,747 | Jun 02 |
| Nestor John G. | Director | May 15 '26 | Sale | 11.22 | 6,055 | 67,929 | 4,364 | May 20 |
| Taylor Francis | Treasurer | Mar 20 '26 | Buy | 11.22 | 232 | 2,603 | 441 | Mar 23 |
| Chi Alex | CEO | Mar 09 '26 | Buy | 10.79 | 9,000 | 97,127 | 9,000 | Mar 10 |
| Nestor John G. | Director | Mar 06 '26 | Sale | 11.29 | 4,401 | 49,690 | 5,516 | Mar 09 |
| Hennigan Thomas M | CFO and President | Mar 04 '26 | Buy | 11.26 | 4,430 | 49,882 | 101,325 | Mar 05 |
| Nestor John G. | Director | Nov 14 '25 | Sale | 11.87 | 7,085 | 84,099 | 7,508 | Dec 02 |
| Hennigan Thomas M | CFO | Nov 13 '25 | Buy | 12.04 | 8,400 | 101,136 | 96,895 | Nov 17 |
| Joseph Nelson | PAO | Nov 10 '25 | Buy | 11.84 | 1,500 | 17,760 | 1,500 | Nov 12 |
| Hennigan Thomas M | CFO | Aug 20 '25 | Buy | 13.75 | 7,285 | 100,169 | 88,495 | Aug 21 |
| Nestor John G. | Director | Aug 18 '25 | Sale | 13.49 | 13,238 | 178,581 | 14,593 | Aug 21 |
| Jenkins Mark David | Director | Nov 22 '24 | Buy | 16.79 | 3,801 | 63,819 | 98,320 | Nov 25 |
| Jenkins Mark David | Director | Nov 12 '24 | Buy | 16.64 | 35,000 | 582,400 | 94,519 | Nov 19 |
| Jenkins Mark David | Director | Nov 11 '24 | Buy | 16.50 | 30,000 | 495,000 | 59,519 | Nov 19 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.